Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

127 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    European Union And United States Agree On Import Tariffs For Pharmaceutical Products

    On 21 August 2025, the European Union and the United States published a Joint Statement (JS) "on a United States-European framework on an agreement on reciprocal...
    GlobalInternational Law
    Van Bael & Bellis
    Van Bael & Bellis
  • Article

    The Ailing Clinical Trials Directive

    The European Commission has started to consider whether Directive 2001/ 20/EC, better known as the Clinical Trials Directive (the Directive), needs to be revised.
    European UnionFood, Drugs, Healthcare, Life Sciences
    Howrey LLP
    Howrey LLP
Article

ECJ Clarifies Scope Of Supplementary Protection Certificate

On 9 February 2012, the Court of Justice of the European Union (the "ECJ") answered a preliminary question referred to it by the High Court of Justice of England and Wales (the "Referring Court") in Novartis AG ("Novartis") v. Actavis UK Ltd.
European UnionIntellectual Property
Van Bael & Bellis
Van Bael & Bellis
  • Article

    COVID-19 Key EU Developments, Policy & Regulatory Update No. 83

    This regular update (no. 83 | 6 June 2022 ) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines, Medical Devices...
    European UnionCoronavirus (COVID-19)
    Jones Day
    Jones Day
  • Article

    Belgium Garners European Support For Initiative To Improve Security Of Medicines Supply In Europe

    On 2 May 2023, the Belgian federal Minister of Social Security and Health published a brief policy document defining three proposed action points to deal with medicine shortages in the EU
    European UnionFood, Drugs, Healthcare, Life Sciences
    Van Bael & Bellis
    Van Bael & Bellis
  • Article

    No Patentability For Products Of Essentially Biological Processes

    Following this decision, the European Parliament asked the Commission in December 2015 to look into the patentability of these products.
    European UnionIntellectual Property
    Van Bael & Bellis
    Van Bael & Bellis
  • Article

    European Commission Proposes To Up-classify Certain Beauty Equipment Falling Within EU Medical Devices Regulation

    The European Commission has adopted a draft implementing regulation that will up-classify certain products without a medical purpose that nevertheless fall within the scope...
    European UnionFood, Drugs, Healthcare, Life Sciences
    Cooley LLP
    Cooley LLP
  • Article

    European Commission Publishes MDR And IVDR Factsheet For Non-EU/EEA Countries

    On 12 July 2023, the European Commission published a factsheet for authorities outside the European Union (EU) and the European Economic Area (EEA)...
    European UnionFood, Drugs, Healthcare, Life Sciences
    Cooley LLP
    Cooley LLP
  • Article

    New Year, New Policy: CPVO Updates Its Public Access To Documents Policy

    The Community Plant Variety Office (CPVO) recently revised its public access to documents policy to align with the European Union (EU)'s evolving transparency standards.
    BelgiumIntellectual Property
    ALTIUS
    ALTIUS
  • Article

    European Commission Opens First Formal Antitrust Investigation In The Medical Devices Sector

    The European Commission has launched its first formal antitrust investigation in the medical devices sector, examining whether Align Technology may have abused its dominant position by restricting interoperability between its Invisalign clear aligners and competing intra-oral scanners. The investigation focuses on allegations that the company created a closed ecosystem, forcing dental professionals to purchase iTero scanners to access Invisalign products for their patients.
    European UnionAntitrust/Competition Law
    A&O Shearman
    A&O Shearman
  • Video

    Understanding Sunshine Rules: How New Transparency Regulations In Europe Are Changing Relationships Between Industry And Health Care Professionals (Video)

    The 2010 Physician Payments Sunshine Act created a new standard of transparency for financial relationships between pharmaceutical companies and health care professionals in the U.S.
    European UnionFood, Drugs, Healthcare, Life Sciences
    Hogan Lovells
    Hogan Lovells
  • Article

    Belgian Medicines Agency Announces Stricter Monitoring Of Negative Formulations On Medicines Packaging

    On 17 May 2023, the Belgian Medicines Agency (FAMHP) announced that marketing authorisation holders (MAHs) have three years to comply with the prohibition of "negative formulations" on the packaging...
    BelgiumFood, Drugs, Healthcare, Life Sciences
    ALTIUS
    ALTIUS
  • Article

    Three Changes In Belgian Food Law In 2023

    Food law is extensively harmonized throughout the EU, but national law still has a role to play. In this short article, we look at three developments in Belgian food law that have taken place in 2023...
    BelgiumFood, Drugs, Healthcare, Life Sciences
    ALTIUS
    ALTIUS
  • Article

    COVID-19 Key EU Developments, Policy & Regulatory Update No. 66

    European Commission approves new and amended Member State measures to support the economy...
    European UnionCoronavirus (COVID-19)
    Jones Day
    Jones Day
  • Article

    EMA Launches Pilot Program For Expert Panel Scientific Advice In Relation To Certain High-risk Devices

    Ten medical device and IVD developers will receive free advice on their clinical development strategies from medical device expert panels.
    BelgiumFood, Drugs, Healthcare, Life Sciences
    Cooley LLP
    Cooley LLP
  • Article

    The EU Pharma Package: Formal Adoption In Sight

    With formal adoption by both the Council of the EU and the EU Parliament expected by summer 2026, stakeholders should start looking into implementation preparations...
    European UnionFood, Drugs, Healthcare, Life Sciences
    Crowell & Moring LLP
    Crowell & Moring LLP
  • Article

    Changes In The Law On Marketing Of Veterinary Medicines: What You Need To Know

    Belgium is welcoming a significant development in the field of veterinary medicine law. The Act of 11 July 2023 containing various provisions on health, which entered into force on 8 September 2023...
    BelgiumFood, Drugs, Healthcare, Life Sciences
    ALTIUS
    ALTIUS
  • Article

    FDA Addresses Industry Feedback On Routine Inspections By Formalizing Processes And Standards In A Draft Guidance

    On 29 March 2019 the U.S. Food and Drug Administration's (FDA) Office of Regulatory Affairs issued a draft guidance document titled "Review and Update of Device Establishment Inspection
    BelgiumFood, Drugs, Healthcare, Life Sciences
    Hogan Lovells
    Hogan Lovells
  • Article

    European Institutions Agree On The Reform To The EU Regulatory Framework For Medicinal Products

    On 11 December, after overnight interinstitutional negotiations between the European Parliament and the Council of the European Union ("Council") and the European Commission...
    European UnionFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    Productwise Bitesize: Clinical Trials Regulation

    Cooley's Productwise Bitesize brings you a short overview of the transitional provisions in the new Clinical Trials Regulation.
    European UnionFood, Drugs, Healthcare, Life Sciences
    Cooley LLP
    Cooley LLP
  • Showing 21–40 of 127 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics